Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 8, 2003, Pages 891-902

  Teoh, Narci C ^a   Farrell, Geoffrey C ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Adenosine; Adhesion molecules; Cell cycle entry; Hepatic ischemia reperfusion injury; Ischemic preconditioning; Kupffer cells; Microcirculation; Neutrophils; Nitric oxide; Reactive oxygen species; Tumor necrosis factor

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CELL DEATH; ENERGY METABOLISM; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATORY CELL; KUPFFER CELL; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER PROTECTION; LIVER SINUSOID; MEMBRANE PERMEABILITY; MICROCIRCULATION; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENICITY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0042855206     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03056.x     Document Type: Review

References (104)

1. Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pretreatment before transplantation. Am. J. Surg. 1975; 129: 513-17.
2. Lemasters JJ, Ji S, Thurman RG. Centrilobular injury following hypoxia in isolated, perfused rat liver. Science 1981; 213: 661-3.
3. Lentsch AB, Atsushi K, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-73.
4. Shiratori Y, Ohmura K, Hikiba Y. Hepatocyte nitric oxide production is induced by Kupffer cells. Dig. Dis. Sci. 1998; 43: 1737-45.
5. Rizzardini M, Zappone M, Villa P et al. Kupffer cell depletion partially prevents hepatic heme oxygenase 1 messenger RNA accumulation in systemic inflammation in mice: role of interleukin 1β. Hepatology 1998; 27: 703-10.
6. Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am. J. Physiol. 1991; 260: G355-62.
7. Jaeschke H, Farhood A, Bautista AP. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am. J. Physiol. 1993; 264: G801-9.
8. Ozaki M, Deshpande SS, Angkeow P et al. Inhibition of the Rac1 GTPase protects against non-lethal ischemic/reperfusion-induced necrosis and apoptosis in vivo. FASEB J. 2000; 14: 418-29.
9. Xia ZF, Horton JW, Zhao PY. Effects of ischemia on intra-cellular sodium and phosphates in the in vivo rat liver. J. Appl. Physiol. 1996; 81: 1395-403.
10. Currin RT, Gores GJ, Thurman RG. Protection by acidotic pH against anoxic cell killing in perfused rat liver: evidence for a pH paradox. FASEB J. 1991; 5: 207-10.
11. Bond JM, Chacon E, Herman B. Intracellular pH and calcium homeostasis during the pH paradox of reperfusion injury to cultured neonatal rat cardiac myocytes. Am. J. Physiol. 1993; 265: C129-37.
12. Gores GJ, Niemenan AL, Wray BE. Intracellular pH during 'chemical hypoxia' in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J. Clin. Invest. 1989; 83: 386-96.
13. Lichtman SN, Lemasters JJ. Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Sem. Liver Dis. 1999; 19: 171-87.
14. Imberti R, Nieminen AL, Duncan PR. Mitochondrial inhibition and uncoupling preceding lethal injury to rat hepatocytes by t-butyl hydroperoxide, protection by fructose, oligomycin, cyclosporin A and trifluoperazine. Hepatology 1990; 12: 933-7.
15. Fujii Y, Johnson ME, Gores GJ. Mitochondrial dysfunction during anoxia/reoxygenation injury of liver sinusoidal endothelial cells. Hepatology 1994; 20: 177-85.
16. Nishimura Y, Romer LH, Lemasters JJ. Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured hepatic sinusoidal endothelial cells: the pH paradox and cytoprotection by glucose, acidotic pH and glycine. Hepatology 1998; 27: 1039-49.
17. Samarasinghe DA, Farrell GC. Role of oxidative stress in hypoxia-reoxygenation injury to cultured rat hepatic sinusoidal endothelial cells. Hepatology 2000; 31: 160-5.
18. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion induced damage in isolated rat hearts. J. Mol. Cardiol. 1993; 25: 1461-9.
19. Qian T, Nieminen AL, Herman B. Mitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes. Am. J. Physiol. 1997; 273: C1783-92.
20. Marsh DC, Verugdenhil PK, Mack VE. Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology 1993; 17: 91-8.
21. Zhong Z, Jones S, Thurman RG. Glycine minimizes reperfusion injury in a low-flow liver perfusion model in the rat. Am. J. Physiol. 1996; 270: G332-8.
22. Nichols JC, Bronk SF, Mellgren RL, Gores GJ. Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology 1994; 106: 168-76.
23. Venkatachalam MA, Weinberg JM, Patel Y. Cytoprotection of kidney epithelial cells by compounds that target amino acid gated chloride channels. Kidney Int. 1996; 49: 449-60.
24. Semenza GL. HIF-1: mediator of physiological and pathophysiological response to hypoxia. J. Appl. Physiol. 2000; 88: 1474-80.
25. Li C, Jackson RM. Reactive oxygen species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. 2002; 282: C227-41.
26. McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. N. Engl. J. Med. 1985; 312: 159-63.
27. Semenza GL. Cellular and molecular dissection of reperfusion injury ROS within and without. Circ. Res. 2000; 86: 117-18.
28. Schinetti ML, Sabarbati R, Scarlattini M. Superoxide production by human umbilical vein endothelial cells in an anoxia-reoxygenation model. Cardiovasc Res. 1989; 23: 76-80.
29. De Groot H, Anundi I, Littauer A. Hypoxia-reoxygenation injury and the generation of reactive oxygen in isolated hepatocytes. Biomed. Biochim. Acta 1989; 48: S11-15.
30. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108: 1849-54.
31. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 1995; 146: 1220-34.
32. Baker SJ, Reddy EP. Modulation of life and death by the tumor necrosis receptor superfamily. Oncogene 1998; 17: 3261-70.
33. Yamauchi N, Kuriyama H, Watanabe N, Neba H, Maeda M, Niitsu Y. Intercellular hydroxyl production induced by recombinant human TNF and its implication in the killing of tumor cells in vitro. Cancer Res. 1989; 49: 1671-5.
34. Goosens V, Grooten J, Kurt V, Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl Acad. Sci. USA 1995; 92: 8115-19.
35. Wanner GA, Ertel W, Muller P. Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 1996; 5: 34-40.
36. Shirasugi N, Wakabayashi G, Shimazu M. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997; 64: 1398-403.
37. Rudiger HA, Clavien P. Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 2002; 122: 202-10.
38. Lentsch AB, Yoshidome H, Kato A et al. Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 1999; 30: 1448-53.
39. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-20.
40. Muraoka KI, Shimizu K, Sun X. Hypoxia, but not reoxygenation, induces IL-6 gene expression through NF-κB activation. Transplantation 1997; 63: 466-70.
41. Clavien PA, Camargo CA, Gorczynski R. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and non-cirrhotic human livers. Hepatology 1996; 23: 1456-63.
42. Colletti LM, Kunkel SL, Walz A. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J. Clin. Invest. 1995; 95: 134-41.
43. Colletti LM, Kunkel SL, Walz A. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996; 23: 506-14.
44. Yoshimura T, Matsushima K, Oppenheim JJ. Neutrophil chemotactic factor produced by LPS-stimulated human blood mononuclear leukocytes: partial characterization and separation from IL-1. J. Immunol. 1987; 139: 788-93.
45. Hisama N, Yamaguchi Y, Ishiko T. Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rats. Hepatology 1996; 24: 1193-8.
46. Lentsch AB, Yoshidome H, Cheadle WG. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology 1998; 27: 507-12.
47. Clemens MG. Nitric oxide in liver injury. Hepatology 1999; 30: 1-5.
48. Shah V, Haddad FG, Garcia-Cardena G. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J. Clin. Invest. 1997; 100: 2923-30.
49. Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998; 114: 344-51.
50. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am. J. Surg. 2001; 181: 160-6.
51. Geller DA, de Vera ME, Russell DA. A central role for IL-1β in the in vitro regulation of hepatic inducible nitric oxide synthase. J. Immunol. 1995; 155: 4890-8.
52. Cottart CH, Do L, Blanc MC. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 1999; 29: 809-13.
53. 2 receptors. Hepatology 1999; 29: 126-32.
54. Hur GM, Ryu YS, Yun HY et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappa B. Biochem. Biophys. Res. Comm. 1999; 261: 917-22.
55. Koeppel TA, Thies JC, Schemmer P. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J. Hepatol. 1997; 27: 163-9.
56. Dhar DK, Yamanoi A, Ohmori H. Modulation of endothelin and nitric oxide: a rational approach to improve canine hepatic microcirculation. Hepatology 1998; 28: 782-8.
57. Ohmori H, Dhar DK, Nakashima Y. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Transplantation 1998; 66: 579-85.
58. Shihamura T, Zhu Y, Zhang S. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J. Am. Coll. Surg. 1999; 188: 43-52.
59. Farghali H, Zidek Z, Hynie S. Effects of nitroprusside as a nitric oxide donor on anoxia/reoxygenation and D-galactosamine hepatic injuries: a study in perfused hepatocytes. Physiol. Res. 1997; 46: 363-9.
60. Marzi I, Takei Y, Ruker M. Endothelin-1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion. Transplant Int. 1994; 7: S503-6.
61. Kawamura E, Yamanaka N, Okamoto E. Response of plasma and tissue endothelin-1 to liver ischemia and its implications in ischemia-reperfusion injury. Hepatology 1995; 21: 1138-43.
62. Pannen BHJ, Al-Adili F, Bauer M. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 1998; 27: 755-64.
63. Scommotau S, Uhlmann D, Loeffler BM. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury. Arch. Surg. 1999; 384: 65-70.
64. Shiraishi M, Hiroyasu S, Nagahama M. Role of exogenous 1-arginine in hepatic ischemia-reperfusion injury. J. Surg. Res. 1997; 69: 429-34.
65. Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic ischemia/reperfusion. Am. J. Physiol. 1998; 275: H2191-8.
66. Murphy HS, Warner RL, Bakopoulos N. Endothelial cell determinants of susceptibility to neutrophil-mediated killing. Shock 1999; 12: 111-17.
67. Kim YM, deVera ME, Watkins SC. Nitric oxide protects cultured hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 1997; 272: 1402-11.
68. Sergent O, Griffon B, Morel I. Effect of nitric oxide on iron-mediated oxidative stress in primary hepatocyte culture. Hepatology 1997; 25: 122-7.
69. Vollmar B, Glasz J, Leiderer R. Hepatic microcirculatory perfusion failure is a determinant for liver dysfunction in warm ischemia-reperfusion. Am. J. Pathol. 1994; 145: 1421-31.
70. Vollmar B, Glasz J, Post S. Role of microcirculatory derangements in manifestation of portal triad cross-clamping-induced hepatic reperfusion injury. J. Surg. Res. 1996; 60: 49-54.
71. Jones SM, Thurman RG. 1-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996; 24: 163-8.
72. Martinez-Mier G, Toledo-Pereyra LH, Ward PA. Adhesion molecules in liver ischemia and reperfusion. J. Surg. Res. 2000; 94: 185-94.
73. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J. Clin. Invest. 1997; 99: 2682-90.
74. Essani EA, Fisher MA, Simmons CA, Hoover JL, Farhood A, Jaeschke H. Increased P-selectin expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J. Leukocyte Biol. 1998; 63: 288-96.
75. Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M. Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology 1996; 24: 533-8.
76. Adams DH, Burra P, Hubscher SG, Elias E, Newman V. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 1994; 19: 588-94.
77. Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemia-reperfusion injury. Thromb. Haemost. 1997; 78: 310-14.
78. Sawaya DA, Zibari GB, Minardi A et al. P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. Shock 1999; 12: 227-32.
79. Singh I, Zibari GB, Brown MF et al. Role of P-selectin in hepatic ischemia and reperfusion injury. Clin. Transplant. 1999; 13: 76-82.
80. Zibari GB, Brown MF, Burney N, Granger N, McDonald JC. Role of P-selectin in the recruitment of leukocytes in mouse liver exposed to ischemia and reperfusion. Transplant. Proc. 1998; 30: 2327-30.
81. Yadav SS, Howell D, Steeber D, Harland RC, Tedder TF, Clavien PA. P-selectin mediates reperfusion injury through neutrophil sequestration in the warm ischemic mouse liver. Hepatology 1999; 29: 1494-502.
82. Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. 1-selectin and ICAM-1 mediate neutrophil adhesion and reperfusion injury in the warm ischemic mouse liver. Am. J. Physiol. 1998; 275: G1341-52.
83. Burke J, Zobari BG, Brown MF et al. Hepatic ischemia-reperfusion injury causes E-selectin upregulation. Transplant. Proc. 1998; 30: 2321.
84. Springer TA. Adhesion receptor of the immune system. Nature 1990; 346: 425-34.
85. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 1993; 11: 767-804.
86. Nakano H, Kuzume M, Namatame K, Yamaguchi M, Kumada K. Efficacy of intraportal injection of anti ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am. J. Surg. 1995; 170: 64-6.
87. Marubayashi S, Oshiro Y, Fukuma A, Okada K, Maeda T, Dohi K. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Transplant. Proc. 1999; 31: 1054.
88. Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995; 117: 195-200.
89. Rosser BG, Gores GJ. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
90. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of prevention of injury in rat liver transplantation. Hepatology 1998; 27: 1652-60.
91. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J. 1999; 13: 253-61.
92. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67: 1099-105.
93. Gujral J, Bucci T, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397-405.
94. Murry CE, Jenning RB, Reimer KA. Preconditioning with ischemia: a delay in lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
95. Peralta C, Closa D, Xaus C, Gelpi E, Rosello-Catafau J, Hotter G. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 1998; 28: 768-73.
96. Teoh N, dela Pena A, Farrell G. Hepatic ischemic pre-conditioning in mice is associated with activation of NF-κB, p38 kinase and cell cycle entry. Hepatology 2002; 36: 94-102.
97. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion. role of nitric oxide and adenosine. Hepatology 1997; 25: 934-7.
98. Peralta C, Bartrons R, Riera L et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am. J. Physiol. 2000; 279: G163-71.
99. Peralta C, Bartrons R, Serafin A et al. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-73.
100. Sawaya DE Jr, Brown M, Minardi A et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J. Surg. Res. 1999; 85: 163-70.
101. Peralta C, Fernandez L, Panes J et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-13.
102. Teoh N, dela Pena A, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-28.
103. Totsuko E, Fung JJ, Urakami A, Moras N, Ishii T, Takahashi K. Influence of donor cardiopulmonary arrest in human liver transplantation. Hepatology 2000; 31: 577-80.
104. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 2000; 232: 163-5.